First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2010-01-15 11:00:18Open Document File Size: 40,85 KBShare Result on FacebookCompanySabin Vaccine Institute BETHESDA / MVI / / /FacilityThe George Washington University / Sabin Vaccine Institute / Sabin Vaccine Institute Sabin Vaccine Institute / Johns Hopkins Malaria Research Institute / /IndustryTermappropriate health technologies / long-term solutions / important tool / /MedicalConditionoral polio vaccine / disease / epidemic / malaria / deadliest malaria / clinical disease / malaria infection / pain / injury / infectious and neglected diseases / illness / /MedicalTreatmentvaccination / /OrganizationMelinda Gates Foundation / PATH PATH / Johns Hopkins Bloomberg School / Johns Hopkins Bloomberg School of Public Health As / Johns Hopkins Bloomberg School of Public Health / The George Washington University / Johns Hopkins Malaria Research Institute / Sabin Vaccine Institute / JHSPH / /PersonPeter Agre / Ami Shah Brown / Rhoel Dinglasan / Christian Loucq / Albert B. Sabin / Timothy Parsons / / /PositionDirector of Vaccine Operations / Director / lead researcher / /Technologyappropriate health technologies / antibodies / /URLwww.jhsph.edu / www.sabin.org / www.malariavaccine.org / www.path.org / /SocialTag |